Piper Jaffray Raises PT On Cepheid To $33

April 21, 2011 6:41 AM | 7 seconds read | Make a Comment

Piper Jaffray has raised the price target on Cepheid

CPHD

from $29 to $33 and maintains its Overweight rating.

Posted In: Price Target Analyst Ratings Biotechnology cepheid Health Care Piper Jaffray

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.